Cite
HARVARD Citation
de Celis-Ruiz, E. et al. (2021). Allogeneic adipose tissue-derived mesenchymal stem cells in ischaemic stroke (AMASCIS-02): a phase IIb, multicentre, double-blind, placebo-controlled clinical trial protocol. BMJ open. 11 (8), p. . [Online].